...
首页> 外文期刊>Cancer Management and Research >Prognostic and predictive value of the macroscopic growth pattern in patients undergoing curative resection of colorectal cancer: a single-institution retrospective cohort study of 4,080 Chinese patients
【24h】

Prognostic and predictive value of the macroscopic growth pattern in patients undergoing curative resection of colorectal cancer: a single-institution retrospective cohort study of 4,080 Chinese patients

机译:宏观生长方式对结直肠癌根治性切除术患者的预后和预测价值:一项针对4,080名中国患者的单机构回顾性队列研究

获取原文
           

摘要

Purpose: The purpose of this study was to determine whether macroscopic growth patterns had an impact on the prognosis of colorectal cancer (CRC) patients with different tumor–node–metastasis (TNM) stages and responses to chemotherapy in stage III patients. Patients and methods: We retrospectively recruited 4,080 stage I–III CRC patients who underwent curative resection at Shandong Provincial Hospital affiliated to Shandong University. All patients were grouped by macroscopic growth patterns (expansive, infiltrative and ulcerative subtypes), and stage III patients were further divided into chemotherapy and nonchemotherapy groups. Kaplan–Meier methods, univariate and multivariate analyses and subset analyses were performed to assess the overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS). Results: Kaplan–Meier survival curves and univariate analyses revealed better OS (HR=0.731; 95% CI=0.584–0.916), CSS (HR=0.714; 95% CI=0.548–0.932) and DFS (HR=0.722; 95% CI=0.602–0.864) in the expansive subtype and worse OS (HR=2.121; 95% CI=1.457–3.088), CSS (HR=2.499; 95% CI=1.664–3.753) and DFS (HR=2.360; 95% CI=1.756–3.170) in the infiltrative subtype. Subset analyses based on the tumor–node–metastasis stage showed that the infiltrative subtype was associated with inferior DFS in stage II (HR=2.357; 95% CI=1.210–4.595) and stage III patients (HR=1.941; 95% CI=1.394–2.702) and inferior OS and CSS in stage III patients (HR=1.805; 95% CI=1.210–2.693 and HR=1.981, 95% CI=1.280–3.065, respectively). In addition, multivariate Cox proportional hazard regression models revealed similar results. Furthermore, in stage III patients, the OS, CSS and DFS in both the expansive and ulcerative subtypes were significantly extended after the administration of chemotherapy (all, P <0.001). However, the OS, CSS and DFS in the infiltrative subtype did not change significantly after the administration of chemotherapy ( P =0.486, 0.290 and 0.731, respectively). Conclusion: The macroscopic growth pattern was an independent prognostic factor among stage I–III CRC patients. The infiltrative subtype had the worst prognosis in stage III patients and did not display survival benefits from chemotherapy.
机译:目的:本研究的目的是确定宏观生长方式是否对不同肿瘤-淋巴结转移(TNM)期的大肠癌(CRC)患者的预后以及对III期患者对化疗的反应是否有影响。患者和方法:我们回顾性收集了4080例在山东大学附属山东省立医院接受根治性切除术的I-III期CRC患者。所有患者均按宏观生长方式(扩张,浸润和溃疡性亚型)分组,III期患者进一步分为化学疗法和非化学疗法组。进行了Kaplan–Meier方法,单变量和多变量分析以及子集分析,以评估总体生存期(OS),癌症特异性生存期(CSS)和无病生存期(DFS)。结果:Kaplan–Meier生存曲线和单因素分析显示更好的OS(HR = 0.731; 95%CI = 0.584-0.916),CSS(HR = 0.714; 95%CI = 0.548–0.932)和DFS(HR = 0.722; 95%扩张亚型和OS较差(HR = 2.121; 95%CI = 1.457-3.088),CSS(HR = 2.499; 95%CI = 1.664-3.753)和DFS(HR = 2.360; 95%)时CI = 0.602–0.864) CI = 1.756–3.170)。基于肿瘤-淋巴结转移阶段的亚组分析表明,浸润性亚型与II期(HR = 2.357; 95%CI = 1.210-4.595)和III期患者(HR = 1.941; 95%CI = 1.394–2.702)和III期患者的OS和CSS较差(HR分别为1.805; 95%CI = 1.210–2.693和HR = 1.981,95%CI = 1.280–3.065)。此外,多元Cox比例风险回归模型显示了相似的结果。此外,在III期患者中,化疗后,扩张型和溃疡性亚型的OS,CSS和DFS均显着延长(所有,P <0.001)。然而,化疗后浸润性亚型的OS,CSS和DFS没有显着变化(分别为P = 0.486、0.290和0.731)。结论:宏观生长方式是I–III期CRC患者的独立预后因素。浸润性亚型在III期患者中预后最差,并且未显示化疗可带来生存益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号